Alliance A059102: A Randomized Phase II US Intergroup Study of CHO(E)P vs CC-486-CHO(E)P vs DUVELISIB-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas
- Citation:
- J Clin Oncol vol 40 (16_suppl) TPS7593-TPS7593
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Neha Mehta-Shah Susan Geyer Nancy Bartlett Stefan Barta Jennifer Amengual Travis Dockter Chadwick Wright Eric Hsi Shira N. Dinner Steven Horwitz Brad Kahl Jonathan Friedberg John Leonard
- Networks:
- COLUMBIA, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NY016, NY018, OH070, PA121
- Study
- Alliance-A051902
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: